USPTO serial 79448985
FERTILIGENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRUNDAGE, DAVID WILLIAM
- Law office
- TMO LAW OFFICE 112
What this means
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
Need help with FERTILIGENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Flavia Campbell
Flavia Campbell Dickinson Wright PLLC1850 North Central Avenue, Suite 1400Phoenix, AZ 85004UNITED STATES OF AMERICAGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SaaS) services featuring software for providing information and educational support in the field of fertility, assisted reproductive technology, and in vitro fertilization; Software as a service (SaaS) services featuring software for providing explanations of laboratory and clinical test results in the field of fertility; Software as a service (SaaS) services featuring software for providing medication schedule information and treatment step checklists in the field of fertility treatment; Software as a service (SaaS) services featuring software for secure messaging and delivery of educational content between fertility clinics and patients; Software as a service (SaaS) services featuring software for generating informational responses to patient questions; Software as a service (SaaS) services featuring software for generating drafts of clinical documentation, namely visit notes, visit summaries, and care instructions; Software as a service (SaaS) services featuring software for generating drafts of patient communications and responses to patient questions; providing temporary use of online non-downloadable software for presenting clinical guideline references and clinic-approved informational sources; providing temporary use of online non-downloadable software for implementing role-based access control, audit logging, and configurable data retention for clinical documentation and patient communications; providing temporary use of online non-downloadable computer software utilizing artificial intelligence, machine learning, deep learning, and predictive analytics for analyzing medical and patient data, generating clinical insights, supporting clinical decision-making, and optimizing clinical workflows; software as a service (SaaS) services featuring artificial intelligence software for deep learning, machine learning, natural language processing, and large language model-based analysis for use in generating patient-specific recommendations, automating clinical and administrative workflow tasks, and enhancing the creation, review, and optimization of clinical documentation; providing temporary use of online non-downloadable computer software that uses artificial intelligence to understand, interpret, and formulate responses to patient queries and healthcare provider instructions; providing temporary use of online non-downloadable software applications for the integration of artificial intelligence, machine learning, data analytics, and automated reasoning into healthcare workflows and clinical information systems; design and development of computer software, algorithms, data processing pipelines, and application programming interfaces (APIs) for system interoperability, data integration, automated data exchange, and secure transfer of clinical or operational healthcare information; providing temporary use of online non-downloadable computer software development tools, model training environments, and model deployment platforms in the field of artificial intelligence, machine learning, and data-driven healthcare technologies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 7, 2026 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2026 | ALIE | ASSIGNED TO LIE | — |
| Oct 5, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 18, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 16, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 1, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |